NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Cancer|Advanced Solid Tumor|Neoplasm Malignant|Metastatic Cancer|Melanoma|Classical Hodgkin Lymphoma|Non Small Cell Lung Cancer|Renal Cell Carcinoma|Urothelial Carcinoma|Head and Neck Squamous Cell Carcinoma|Subungual Squamous Cell Carcinoma|Oesophageal Carcinoma|MSI-H Colorectal Cancer|Gastric Cancer|Triple Negative Breast Cancer|Endometrial Carcinoma|Pleural Mesothelioma
Interventions: DRUG: Fosifloxuridine Nafalbenamide|DRUG: Leucovorin|DRUG: Pembrolizumab|DRUG: Docetaxel
Sponsor: NuCana plc